Literature DB >> 24823966

Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.

Kazuo Yamamura1, Hiroyuki Sugimoto, Mitsuro Kanda, Suguru Yamada, Shuji Nomoto, Goro Nakayama, Tsutomu Fujii, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera.   

Abstract

BACKGROUND: Various inflammation-based prognostic scores, including the Glasgow prognostic score (GPS), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), prognostic index (PI), and prognostic nutritional index (PNI), have been associated with survival in patients with several types of cancer. This study compared the ability of these scores to predict recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) after curative hepatectomy.
METHODS: Data were collected prospectively from 113 patients who underwent curative resection for HCC from January 2003 to December 2012. Clinicopathological variables including preoperative inflammation-based prognostic scores were analyzed. Univariate and multivariate analyses were performed to identify factors predictive of RFS.
RESULTS: Univariate analysis showed that NLR (P < 0.0001) and PI (P = 0.0194) were significantly associated with RFS. Multivariate analysis showed that NLR (hazard ratio [HR]; 2.58, P = 0.0020), tumor differentiation (HR; 9.55, P < 0.0001), serosal invasion (HR; 2.24, P = 0.0112), and vascular invasion (HR; 2.18, P = 0.0106) were independently correlated with RFS.
CONCLUSIONS: Preoperative NLR is an independent predictor of RFS in patients with HCC after curative hepatectomy, and is superior to the other inflammation-based prognostic scores.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Cancer recurrence; Hepatocellular carcinoma; Inflammation-based prognostic score

Mesh:

Substances:

Year:  2014        PMID: 24823966     DOI: 10.1002/jhbp.114

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  36 in total

1.  Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma.

Authors:  Yuxin Guo; Darren W Chua; Ye-Xin Koh; Ser-Yee Lee; Peng-Chung Cheow; Juinn-Huar Kam; Jin-Yao Teo; Pierce K Chow; Alexander Y Chung; London L Ooi; Chung-Yip Chan; Brian K P Goh
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Preoperative inflammatory response as prognostic factor of patients with colon cancer.

Authors:  Daiki Matsubara; Tomohiro Arita; Masayoshi Nakanishi; Yoshiaki Kuriu; Yasutoshi Murayama; Michihiro Kudou; Katsutoshi Shoda; Toshiyuki Kosuga; Hirotaka Konishi; Ryo Morimura; Atsushi Shiozaki; Hisashi Ikoma; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Langenbecks Arch Surg       Date:  2019-08-29       Impact factor: 3.445

3.  Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection.

Authors:  Mitsugi Shimoda; Kazuma Tago; Takayuki Shiraki; Shozo Mori; Masato Kato; Taku Aoki; Keiichi Kubota
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

4.  Postoperative Prognostic Nutritional Index Predicts Survival of Patients with Hepatocellular Carcinoma within Milan Criteria and Hypersplenism.

Authors:  Xiaoyun Zhang; Chuan Li; Tianfu Wen; Wei Peng; Lunan Yan; Jiayin Yang
Journal:  J Gastrointest Surg       Date:  2017-05-18       Impact factor: 3.452

5.  Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer.

Authors:  Zi-Quan Zhou; Shuo Pang; Xing-Chen Yu; Qi Xue; Hong-Yu Jiang; Xin-Jun Liang; Li Liu
Journal:  Curr Med Sci       Date:  2018-10-20

6.  The impact of postoperative inflammation on recurrence in patients with colorectal cancer.

Authors:  Daiki Matsubara; Tomohiro Arita; Masayoshi Nakanishi; Yoshiaki Kuriu; Yasutoshi Murayama; Michihiro Kudou; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Eigo Otsuji
Journal:  Int J Clin Oncol       Date:  2019-11-22       Impact factor: 3.402

7.  Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma.

Authors:  Martin F Sprinzl; Martha M Kirstein; Sandra Koch; Marie-Luise Seib; Julia Weinmann-Menke; Hauke Lang; Christoph Düber; Gerrit Toenges; Daniela Zöller; Jens U Marquardt; Marcus-Alexander Wörns; Peter R Galle; Arndt Vogel; Matthias Pinter; Arndt Weinmann
Journal:  Liver Cancer       Date:  2018-10-04       Impact factor: 11.740

8.  Utility and Limitation of Preoperative Neutrophil Lymphocyte Ratio as a Prognostic Factor in Hepatocellular Carcinoma.

Authors:  Ei Uchinaka; Masataka Amisaki; Masaki Morimoto; Naruo Tokuyasu; Teruhisa Sakamoto; Soichiro Honjo; Hiroaki Saito; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2018-12-27       Impact factor: 1.641

9.  Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.

Authors:  Rui Liao; Zhuo-Wei Tang; De-Wei Li; Shi-Qiao Luo; Ping Huang; Cheng-You Du
Journal:  World J Surg Oncol       Date:  2015-09-02       Impact factor: 2.754

10.  Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.

Authors:  Suguru Yamada; Tsutomu Fujii; Norimitsu Yabusaki; Kenta Murotani; Naoki Iwata; Mitsuro Kanda; Chie Tanaka; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.